Citation Impact
Citing Papers
Daily Oral Everolimus Activity in Patients With Metastatic Pancreatic Neuroendocrine Tumors After Failure of Cytotoxic Chemotherapy: A Phase II Trial
2009
Identification of human renal cell carcinoma associated genes by suppression subtractive hybridization
2001
Gene array of VHL mutation and hypoxia shows novel hypoxia-induced genes and that cyclin D1 is a VHL target gene
2004 StandoutNobel
Treatment of kidney cancer
2009 StandoutNobel
Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group
2007 Standout
Concurrent Cisplatin-Based Radiotherapy and Chemotherapy for Locally Advanced Cervical Cancer
1999 Standout
Pancreatic cancer
2004 Standout
Cisplatin, Radiation, and Adjuvant Hysterectomy Compared with Radiation and Adjuvant Hysterectomy for Bulky Stage IB Cervical Carcinoma
1999 Standout
Management of cancer pain
1999 Standout
pVHL Acts as an Adaptor to Promote the Inhibitory Phosphorylation of the NF-κB Agonist Card9 by CK2
2007 StandoutNobel
Clinical trials in primary hepatocellular carcinoma: current status and future directions
1988
Everolimus for Advanced Pancreatic Neuroendocrine Tumors
2011 Standout
Hypocomplementemia Discloses Genetic Predisposition to Hemolytic Uremic Syndrome and Thrombotic Thrombocytopenic Purpura
1999
von Willebrand Factor–Cleaving Protease in Thrombotic Thrombocytopenic Purpura and the Hemolytic–Uremic Syndrome
1998 Standout
The von Hippel–Lindau tumour suppressor protein: O2 sensing and cancer
2008 StandoutNobel
Enzymatic Targeting of the Stroma Ablates Physical Barriers to Treatment of Pancreatic Ductal Adenocarcinoma
2012 Standout
Improved Survival in Thrombotic Thrombocytopenic Purpura–Hemolytic Uremic Syndrome
1991
New Insights into the Biology of Renal Cell Carcinoma
2011 StandoutNobel
Distinct Populations of Cancer Stem Cells Determine Tumor Growth and Metastatic Activity in Human Pancreatic Cancer
2007 Standout
Pancreatic cancer
2016 Standout
Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice
2005 Standout
Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.
1997 Standout
Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome
2005 Standout
Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors
2011 Standout
Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura
2001 StandoutNature
Chemotherapy for pancreatic carcinoma
1996
Pancreatic Adenocarcinoma
2014 Standout
Management of Hepatocellular Carcinoma *
2005 Standout
Long-term follow-up of potentiation of radiotherapy by cis-platinum in advanced cervical cancer
1989
Comparison of Plasma Exchange with Plasma Infusion in the Treatment of Thrombotic Thrombocytopenic Purpura
1991 Standout
Biology of Natural Killer Cells
1989 Standout
Regulation of Hypoxia-Inducible Factor-1α, Vascular Endothelial Growth Factor, and Angiogenesis by an Insulin-Like Growth Factor-I Receptor Autocrine Loop in Human Pancreatic Cancer
2003 StandoutNobel
Recent advances with liposomes as pharmaceutical carriers
2005 Standout
Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL Conference
2001 Standout
Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-α targeting: first in-human results
2011 Standout
The Molecular Basis of Familial Hemolytic Uremic Syndrome
2001
Improved local control of invasive bladder cancer by concurrent cisplatin and preoperative or definitive radiation. The National Cancer Institute of Canada Clinical Trials Group.
1996
The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans
2021 StandoutNobel
Vincristine sulfate for the treatment of thrombotic thrombocytopenic purpura refractory to plasma‐exchange
1994
Adjuvant Chemotherapy With Gemcitabine vs Observation in Patients Undergoing Curative-Intent Resection of Pancreatic Cancer
2007 Standout
Complement
2001 Standout
Pancreatic Cancer
2010 Standout
Disseminated Intravascular Coagulation
1999 Standout
The pathophysiology and management of thrombotic thrombocytopenic purpura
1996
Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised, placebo-controlled, phase 3 study
2011 Standout
Folate receptor expression in carcinomas and normal tissues determined by a quantitative radioligand binding assay
2005 Standout
Poor outcome in disseminated intravascular coagulation or thrombotic thrombocytopenic purpura patients with severe vascular endothelial cell injuries
1998
Antibodies to von Willebrand Factor–Cleaving Protease in Acute Thrombotic Thrombocytopenic Purpura
1998 Standout
Pancreatic cancer
2011 Standout
Rituximab for chronic recurring thrombotic thrombocytopenic purpura: a case report and review of the literature
2004
Preliminary results of concurrent radiotherapy and chemotherapy with cis-platinum, vincristine, and bleomycin in bulky, advanced cervical carcinoma: A pilot study
1992
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Maturation of the hemostatic system during childhood
1992 Standout
Treatment of Thrombotic Thrombocytopenic Purpura with Plasma
1977
Pathologic effects of plasma from patients with thrombotic thrombocytopenic purpura on platelets and cultured vascular endothelial cells
1982
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
2011 Standout
Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology [see comments]
1996 Standout
Epidermal growth factor receptor blockade with C225 plus gemcitabine results in regression of human pancreatic carcinoma growing orthotopically in nude mice by antiangiogenic mechanisms.
2000
Immunoadsorption for Removal of a and B Blood-Group Antibodies
1981 StandoutNobel
Presence of a platelet aggregating factor in the plasma of patients with thrombotic thrombocytopenic purpura (TTP) and its inhibition by normal plasma
1979
Mechanisms of Cisplatin Nephrotoxicity
2010 Standout
Cis-diamminedichloroplatinum II based combination chemotherapy for the control of extensive paraaortic lymph node metastasis in cervical cancer
1987
Safety and efficacy of the antiganglioside GD3 antibody ecromeximab (KW2871) combined with high-dose interferon-α2b in patients with metastatic melanoma
2017
Unusually Large Plasma Factor VIII: von Willebrand Factor Multimers in Chronic Relapsing Thrombotic Thrombocytopenic Purpura
1982 Standout
The Hypercoagulable States
1985
Chemotherapy prolongs survival in inoperable pancreatic carcinoma
1994
Somatic inactivation of the PHD2 prolyl hydroxylase causes polycythemia and congestive heart failure
2007 StandoutNobel
Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States
2017 Standout
Deficient Activity of von Willebrand Factor–Cleaving Protease in Chronic Relapsing Thrombotic Thrombocytopenic Purpura
1997
Simultaneous radiation and chemotherapy for advanced carcinoma of the cervix
1987
Phase I Trial of Twice-Weekly Gemcitabine and Concurrent Radiation in Patients With Advanced Pancreatic Cancer
1999
Plasmapheresis in the treatment of thrombotic thrombocytopenic purpura
1977
International experiences with the Hospital Anxiety and Depression Scale-A review of validation data and clinical results
1997 Standout
One‐Year Follow‐Up of Plasma Exchange Therapy in 14 Patients with Idiopathic Thrombocytopenic Purpura
1981
Folate targeting of haptens to cancer cell surfaces mediates immunotherapy of syngeneic murine tumors
2002
Role of the Vascular Endothelial Growth Factor Pathway in Tumor Growth and Angiogenesis
2004 Standout
T-Lymphocyte–Mediated Granulopoietic Failure
1983
Works of Bukowski Rm being referenced
Phase II trial of m-AMSA in hepatocellular carcinoma: a Southwest Oncology Group Study.
1982
Biologic therapy in patients receiving salvage treatment.
1994
Phase II trial of streptozotocin, mitomycin C, and 5-fluorouracil in adenocarcinoma of the pancreas.
1980
Simultaneous treatment with cisplatin and radiation therapy for advanced solid tumors: a pilot study.
1981
Phase Ia-Ib trial of an anti-GD3 monoclonal antibody in combination with interferon-alpha in patients with malignant melanoma.
1990
Cytokine combinations: therapeutic use in patients with advanced renal cell carcinoma.
2000
Treatment of severe aplastic anemia with antithymocyte globulin.
1982
Combination chemotherapy for islet cell carcinoma and metastatic carcinoid tumors with 5-fluorouracil and streptozotocin.
1979
Exchange transfusions in the treatment of thrombotic thrombocytopenic purpura.
1976
Thrombotic thrombocytopenic purpura: a review.
1982